Comparing Inogen (INGN) & Its Rivals

Inogen (NASDAQ:INGN) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its rivals? We will compare Inogen to related companies based on the strength of its institutional ownership, dividends, risk, analyst recommendations, valuation, profitability and earnings.

Institutional & Insider Ownership

89.9% of Inogen shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 2.5% of Inogen shares are owned by company insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Inogen and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Inogen	$348.67 million	-$22.75 million	-4.60
Inogen Competitors	$1.88 billion	$138.79 million	10.05

Inogen’s rivals have higher revenue and earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Inogen and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Inogen	-10.46%	-18.60%	-11.76%
Inogen Competitors	-305.24%	-170.58%	-22.05%

Risk and Volatility

Inogen has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500. Comparatively, Inogen’s rivals have a beta of 2.56, meaning that their average share price is 156% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Inogen and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	1	0	0	1	2.50
Inogen Competitors	4278	10549	18327	829	2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.34%. Given Inogen’s rivals higher probable upside, analysts clearly believe Inogen has less favorable growth aspects than its rivals.

Summary

Inogen rivals beat Inogen on 7 of the 13 factors compared.

Inogen Company Profile

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.